Dawn Flitcraft

President, Ethical Review Division


Photo of Dawn Flitcraft.

Ms. Flitcraft joined WCG in 2016 as a member of the executive team. She is involved in planning and executing corporate strategies designed to accelerate the company’s growth. She collaborates with various stakeholders to ensure that post transaction the necessary people, processes, and technology are in place to achieve success.

Prior to joining WCG, Ms. Flitcraft was chief operating officer and general manager for Keosys Medical Imaging. She was responsible for leading all of the company’s business and operational activities in North America, including sales and marketing, business development, financial, and technological strategies.

Ms. Flitcraft has more than 13 years’ clinical trial experience leading global project management and operational teams at Bioclinica. She started her career there as director, project management at Bio-Imaging Technologies Inc. but was soon promoted to vice president, client services and later senior vice president, client services at Bioclinica. Her customer engagement skills were further recognized and she was appointed vice president, alliance management.

Before that, Ms. Flitcraft held management positions with Quintiles Intelligent Imaging. In addition, she has more than 10 years’ clinical experience in a hospital setting as a nuclear medicine technologist and ultrasonographer.

Ms. Flitcraft earned a BS in nuclear medicine and biology from Cedar Crest College in Allentown PA and she also holds a certification in M&A integration.